| HPV | Human papillomavirus |
| Pap test | Papanicolaou test |
| Lr | Lower risk |
| Hr | High-risk |
| ASC-US | Atypical squamous cells of undetermined significance |
| NPV | Negative predictive value |
| LEEP | Loop electrosurgical excision procedure |
| RFLP | Restriction fragment length polymorphism |
| TMA | Transcription mediated amplification |
| NASBA | Nucleic-acid sequenced based amplification |
| VALGENT | Validation of HPV Genotyping Tests |
| HC2 | Hybrid Capture 2 |
| EIA | Enzyme Immunoassay |
| US FDA | United States Food and Drug Administration |
| LMNX | Luminex |
| IARC | International Agency for Research on Cancer |
| LBC | Liquid-Based Cytology |
| PCR | Polymerase Chain Reaction |